USNA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $14.82
Capitalización Bursátil (MRQ) $274M
P/E (TTM) -7.1
BPA (TTM) $-2.10
Ingresos (TTM) $927M
ROE (TTM) -7.4%
Rango 52S $13–$28

USNA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Divisiones de acciones 3
Fecha ex-dividendo División Tipo
23 de noviembre de 2016 2-for-1 Adelante
31 de octubre de 2003 2-for-1 Adelante
4 de agosto de 1998 2-for-1 Adelante

Acerca de USANA Health Sciences, Inc. Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its brand partnersor by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. In 2026, the Kids Eat program continued efforts to address childhood food insecurity in Utah by providing food bags to students and allowing businesses, families, and other organizations to sponsor participating schools. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

The USANA Foundation was founded in 2012 and has provided hundreds of millions of meals in more than 45 countries. Their programs include USANA Kids Eat and the USANA Garden Towers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

In 2024, USANA acquired a 79% stake in children's health and wellness company Hiya Health in a $260 million transaction, making Hiya a subsidiary of USANA. At the time of the acquisition, Hiya had grown to approximately $100 million in annual sales and offered eight children's health products, including multivitamins, probiotics, iron supplements, and immune support products.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee Brand Partners, as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

USANA sells nutritional, personal care, and food products through Brand Partners and online channels.

USANA classifies Brand Partners and Preferred Customers in its core nutritional business as active customers. There were 387,000 active customers as of January 2026. In 2025, Brand Partners and Preferred Customers each made up about half of all active customers.

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season. USANA provided its products to 40 athletes at the Turin Olympics and worked with various sports organizations, including the Professional Rodeo Cowboys Association.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In 2020, USANA became the title partner of U.S. Ski & Snowboard's training and education facility, the Center of Excellence. The facility is a training hub used by Olympians, youth athletes, and various international competitions.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

USANA began using InCelligence Technology in August 2016 and registered it as a U.S. trademark in March 2017. The technology is used in the company's CellSentials nutritional supplement system, including its Core Minerals and Vita-Antioxidant products, which USANA markets as using its InCelligence Complex to support cellular protection and renewal. As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorConsumer products industriaConsumer products empleados1 570 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$925M
2016-12-31 → 2026-01-03
BPA$0.58
2016-12-31 → 2026-01-03
Flujo de caja libre$9M
2016-12-31 → 2026-01-03
Margen neto-4.2%
2016-12-31 → 2026-01-03
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años USNA promedio 5A Mediana de Pares Veredicto
P/E (TTM) -7.1promedio 5A ≈19.7 ≈19.7 · ·
P/S (TTM) 0.3promedio 5A ≈1.0 ≈1.0 1.2 Infravalorado
P/C (MRQ) 0.5promedio 5A ≈2.3 ≈2.3 2.4 Infravalorado
Precio / FCF (TTM) -16.8promedio 5A ≈20.5 ≈20.5 · ·
Precio / Flujo de Caja (TTM) -157.2promedio 5A ≈13.5 ≈13.5 16.8 Valor razonable
Precio / Valor Contable Tangible (MRQ) 0.7promedio 5A ≈3.0 ≈3.0 · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media -21.9%
Próximo informe Oct 19, 2026
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Jul 20, 2026 $-0.07 $0.44 -116.0%
31 de marzo de 2026 $0.61 $0.45 35.9%
31 de diciembre de 2025 $0.60 $0.42 43.5%
30 de septiembre de 2025 $-0.15 $0.48 -131.3%
30 de junio de 2025 $0.74 $0.55 34.4%
31 de marzo de 2025 $0.73 $0.71 2.2%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 18
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Cost of Revenue $201M$161M$177M$194M$218M$209M$188M$201M$179M$180M$160M$141M
Gross Profit $724M$693M$744M$805M$969M$926M$873M$989M$868M$826M$759M$650M
R&D Expense $11M$12M$11M$12M$11M$11M$10M$10M$9M$9M$6M$5M
SG&A Expense $337M$263M$257M$262M$279M$261M$268M$275M$265M$234M$209M$185M
Operating Expenses $687M$627M$651M$697M$798M$749M$727M$800M$735M$687M$617M$534M
Operating Income $37M$66M$93M$108M$170M$176M$146M$188M$133M$139M$142M$116M
Interest Expense ··$262.0K$192.0K$57.0K$507.0K$66.0K$36.0K$46.0K$444.0K$15.0K$129.0K
Interest Income $2M$11M$10M$4M$3M$3M$5M$4M$2M$1M$1M$500.0K
Other Non-op $3M$-1M$7.0K$-3M$-2M$-571.0K$-335.0K$-1M$-3.0K$-1M$-174.0K$-820.0K
Pretax Income $42M$76M$102M$109M$171M$178M$150M$192M$135M$139M$143M$116M
Income Tax $30M$34M$39M$39M$54M$53M$50M$65M$72M$39M$48M$39M
Net Income $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
EPS (Basic) $0.58$2.20$3.31$3.60$5.78$5.89$4.44$5.24$2.57$4.14$3.72$2.90
EPS (Diluted) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Shares (Basic) 18,535,00019,103,00019,250,00019,254,00020,146,00021,156,00022,644,00024,105,00024,349,00024,185,00025,460,00026,443,000
Shares (Diluted) 18,574,00019,162,00019,345,00019,310,00020,343,00021,256,00022,818,00024,642,00024,708,00025,047,00026,355,00027,377,000
EBITDA $70M$81M$106M$121M$183M$190M$161M$205M$149M$152M$152M$125M
Balance general 26
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents $158M$182M$330M$288M$240M$312M$235M$214M$247M$176M$143M$111M
Receivables $4M···········
Inventory $103M$70M$61M$67M$98M$90M$69M$82M$63M$65M$66M$45M
Prepaid Expense $23M$28M$26M$29M$27M$23M$26M$33M$30M$37M$35M$35M
Other Current Assets $5M$5M$6M$7M$4M$5M$5M$7M$5M$6M$5M$6M
Current Assets $288M$279M$418M$384M$365M$425M$329M$392M$340M$278M$244M$191M
PP&E (Net) $94M$95M$100M$98M$102M$100M$95M$92M$103M$101M$88M$71M
PP&E (Gross) ··$212M$210M$211M$199M$181M$178M$177M$164M$120M$114M
Accum. Depreciation $135M$130M$129M$125M$122M$116M$105M$96M$86M$76M$71M$64M
Goodwill $138M$144M$17M$17M$18M$17M$17M$17M$17M$17M$17M$18M
Intangibles $133M$152M$30M$32M$30M$31M$30M$32M$35M$34M$38M$41M
Other Non-current Assets $62M$59M$55M$55M$58M$62M$43M$18M$21M$22M$25M$24M
Total Assets $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Accounts Payable $17M$12M$10M$11M$14M$18M$13M$10M$12M$9M$10M$8M
Accrued Liabilities $10M$14M$10M·········
Current Liabilities $129M$140M$119M$144M$161M$168M$136M$149M$141M$138M$131M$109M
Capital Leases $12M$10M$5M$8M$10M·$17M·····
Deferred Tax $5M$4M$5M$4M$7M$12M$10M$13M$14M$5M$10M$11M
Other Non-current Liabilities $23M$18M$12M$14M$14M$19M$19M$1M$1M$1M$1M$1M
Total Liabilities $157M$162M$136M·········
Common Stock $18.0K$19.0K$19.0K$19.0K$19.0K$21.0K$22.0K$24.0K$24.0K$24.0K$25.0K$13.0K
Retained Earnings $466M$479M$445M$392M$345M$383M$306M$330M$288M$265M$215M$166M
AOCI $-16M$-23M$-14M$-13M$458.0K$-4M$-14M$-10M$-1M$-12M$-4M$2M
Stockholders' Equity $533M$532M$497M$434M$395M$442M$352M$391M$363M$325M$281M$230M
Liabilities + Equity $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Shares Outstanding 18,281,00019,064,00019,130,00019,206,00019,393,00021,038,00021,655,00023,567,00024,024,00024,485,00024,976,00025,266,000
Flujo de Efectivo 16
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A $33M$15M$13M$13M$13M$14M$15M$17M$16M$13M$10M$9M
Stock-based Comp $14M$15M$15M$13M$14M$14M$16M$15M$15M$17M$11M$10M
Deferred Tax $-7M$-7M$-3M$-7M$-3M$-2M$-4M$607.0K$19M$-4M$-3M$-1M
Amort. of Intangibles $19M$2M$2M$2M$1M$1M$1M$2M$1M$2M$900.0K$431.0K
Restructuring $6M$0$0·········
Other Non-cash $-28M$-3M$-18M$15M$-20M$10M$-442.0K$-7M$10M$11M$-2M$11M
Operating Cash Flow $22M$61M$71M$104M$121M$160M$127M$152M$124M$137M$111M$105M
CapEx $14M$10M$14M$10M$13M$15M$17M$11M$13M$33M$24M$20M
Investing Cash Flow $-10M$-213M$-12M$-12M$-14M$-34M$47M$-69M$-13M$-32M$-25M$-16M
Stock Repurchased $28M$9M$12M$25M$178M$57M$150M$105M$50M$65M$61M$139M
Net Stock Activity $-28M$-9M$-12M$-25M$-178M$-57M$-150M$-105M$-50M$-65M$-61M$-139M
Financing Cash Flow $-41M$10M$-14M$-30M$-181M$-59M$-152M$-105M$-50M$-65M$-49M$-113M
Net Change in Cash $-23M$-149M$42M$48M$-72M$78M$20M$-33M$72M$32M$32M$-26M
Taxes Paid $37M$40M$42M·········
Free Cash Flow $9M$51M$56M$94M$108M$145M$110M$141M$111M$104M$88M$85M
Levered FCF ··$56M$93M$108M$145M$110M$141M$111M$104M$88M$85M
Rentabilidad 8
Métrica Tendencia 202520242023202220212020201920182017201620152014
Gross Margin 78.3%81.1%80.8%80.6%81.6%81.6%82.3%83.1%82.9%82.1%82.6%82.2%
Operating Margin 4.0%7.8%10.1%10.8%14.3%15.6%13.8%15.8%12.7%13.8%15.4%14.7%
Net Margin 1.2%4.9%6.9%6.9%9.8%11.0%9.5%10.6%6.0%9.9%10.3%9.7%
Pretax Margin 4.5%8.9%11.1%10.9%14.4%15.7%14.2%16.1%12.9%13.8%15.5%14.6%
EBITDA Margin 7.6%9.5%11.5%12.1%15.4%16.8%15.2%17.2%14.2%15.1%16.5%15.8%
ROA 1.4%6.1%10.4%11.8%19.1%21.5%18.8%23.5%12.6%22.4%24.5%21.3%
ROE 2.0%7.9%13.2%16.4%29.3%30.0%30.2%30.5%17.2%33.0%37.0%31.2%
ROIC 1.9%6.9%11.7%15.8%29.4%28.0%27.8%31.7%16.9%30.8%33.5%33.4%
Liquidez y Solvencia 3
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 2.22.03.52.72.32.52.42.62.42.01.91.8
Quick Ratio 1.21.32.82.01.51.91.71.41.81.31.11.0
Interest Coverage ··355.2560.52985.8348.12215.05232.02880.5312.29444.1900.0
Eficiencia 2
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 1.21.21.51.71.92.02.02.22.12.32.42.2
Inventory Turnover 2.32.52.72.32.32.22.52.82.82.82.93.0
Por Acción 5
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share $29.16$27.91$25.99$22.62$20.37$20.99$16.24$16.60$15.12$13.29$22.49$18.22
Revenue / Share $49.81$44.59$47.61$51.71$58.32$53.38$46.49$48.26$42.39$40.17$69.70$57.74
Cash Flow / Share $1.20$3.18$3.65$5.38$5.96$7.55$5.55$6.17$5.01$5.47$8.46$7.68
Cash / Share $8.66$9.53$17.27$15.02$12.37$14.83$10.84$9.09$10.29$7.18$11.47$8.80
EPS (TTM) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Tasas de Crecimiento 9
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 8.3%-7.2%-7.8%-15.8%4.6%·······
Revenue CAGR 3Y -2.5%-10.4%-6.7%·········
Revenue CAGR 5Y -4.0%···········
EPS YoY -73.5%-33.6%-8.1%-37.4%-2.2%·······
EPS CAGR 3Y -45.5%-27.4%-17.4%·········
EPS CAGR 5Y -37.0%···········
Net Income YoY -74.4%-34.1%-8.0%-40.5%-6.5%·······
Net Income CAGR 3Y -46.3%-28.8%-20.0%·········
Net Income CAGR 5Y -38.7%···········
Valoración (TTM) 10
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Net Income TTM $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
Market Cap $355M$680M$1.03B$1.02B$1.96B$1.62B$1.73B$2.71B$1.78B$1.50B$798M$646M
P/E 33.516.316.214.817.713.218.122.529.315.317.818.3
P/S 0.40.81.11.01.71.41.62.31.71.50.90.8
P/B 0.71.32.12.45.03.74.96.94.94.62.82.8
P / Tangible Book 1.42.92.32.75.74.1······
P / Cash Flow 15.911.214.59.816.210.113.717.814.410.97.26.1
P / FCF 41.713.418.310.918.111.215.719.316.114.49.17.6
Earnings Yield 3.0%6.1%6.2%6.8%5.7%7.6%5.5%4.5%3.4%6.5%5.6%5.5%

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2026-01-032024-12-282023-12-302022-12-312022-01-01
Ingresos $925M $855M $921M $999M $1.19B
Margen Bruto % 78.3% 81.1% 80.8% 80.6% 81.6%
Margen Operativo % 4.0% 7.8% 10.1% 10.8% 14.3%
Beneficio neto $11M $42M $64M $69M $117M
EPS Diluido $0.58 $2.19 $3.30 $3.59 $5.73

Propietarios institucionales (13F) 152 declarantes · $260.8M total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 152
Valor en tenencia $260.8M
Nuevas posiciones 25
Posiciones cerradas 17
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
25 (-5 vs trimestre anterior) 17 (+8 vs trimestre anterior) 60 (+21 vs trimestre anterior) 30 (-19 vs trimestre anterior) +1.2M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
BlackRock, Inc. $33 181 935 1 554 189 12,73% Acciones
PZENA INVESTMENT MANAGEMENT LLC $25 739 282 1 205 587 9,87% Acciones
RENAISSANCE TECHNOLOGIES LLC $20 464 402 958 520 7,85% Acciones
VANGUARD GROUP INC $18 340 623 934 316 7,03% Acciones
DIMENSIONAL FUND ADVISORS LP $17 878 705 837 426 6,86% Acciones
Nantahala Capital Management, LLC $17 295 080 810 074 6,63% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $10 405 350 487 370 3,99% Acciones
Creative Planning $8 923 681 417 971 3,42% Acciones
AQR CAPITAL MANAGEMENT LLC $8 712 637 408 086 3,34% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $7 758 099 363 377 2,98% Acciones
GEODE CAPITAL MANAGEMENT, LLC $6 047 019 283 165 2,32% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5 811 641 272 208 2,23% Acciones
STATE STREET CORP $5 577 474 261 240 2,14% Acciones
Nuveen, LLC $5 112 835 239 477 1,96% Acciones
AMERICAN CENTURY COMPANIES INC $3 999 880 187 348 1,53% Acciones
JACOBS LEVY EQUITY MANAGEMENT, INC $3 855 105 180 567 1,48% Acciones
TWO SIGMA INVESTMENTS, LP $3 533 724 165 514 1,36% Acciones
MORGAN STANLEY $3 509 150 164 363 1,35% Acciones
D. E. Shaw & Co., Inc. $3 348 427 156 835 1,28% Acciones
Allianz Asset Management GmbH $3 040 219 142 399 1,17% Acciones
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2 949 567 138 153 1,13% Acciones
ALGERT GLOBAL LLC $2 813 033 131 758 1,08% Acciones
GOLDMAN SACHS GROUP INC $2 631 750 123 267 1,01% Acciones
UBS Group AG $2 474 166 115 886 0,95% Acciones
LAZARD ASSET MANAGEMENT LLC $2 077 590 97 311 0,80% Acciones
NORTHERN TRUST CORP $2 016 870 94 467 0,77% Acciones
AMERIPRISE FINANCIAL INC $1 552 893 72 735 0,60% Acciones
VANGUARD FIDUCIARY TRUST CO $1 549 540 72 578 0,59% Acciones
Vanguard Global Advisers, LLC $1 514 569 70 940 0,58% Acciones
Empowered Funds, LLC $1 499 902 70 253 0,58% Acciones
TWO SIGMA ADVISERS, LP $1 289 691 65 700 0,49% Acciones
Bank of New York Mellon Corp $1 104 521 51 734 0,42% Acciones
Quantinno Capital Management LP $1 072 261 50 223 0,41% Acciones
BANK OF AMERICA CORP /DE/ $967 539 45 318 0,37% Acciones
ROYCE & ASSOCIATES LP $884 039 41 407 0,34% Acciones
DEUTSCHE BANK AG\ $821 975 38 500 0,32% Acciones
Assenagon Asset Management S.A. $815 848 38 213 0,31% Acciones
BARCLAYS PLC $777 141 36 400 0,30% Acciones
STRS OHIO $723 765 33 900 0,28% Acciones
Skopos Labs, Inc. $673 696 38 563 0,26% Acciones
HSBC HOLDINGS PLC $672 758 31 960 0,26% Acciones
Invesco Ltd. $670 775 31 418 0,26% Acciones
SEI INVESTMENTS CO $641 513 30 047 0,25% Acciones
XTX Topco Ltd $625 320 29 289 0,24% Acciones
CITADEL ADVISORS LLC $575 617 26 961 0,22% Acciones
MILLENNIUM MANAGEMENT LLC $570 728 26 732 0,22% Acciones
Verdad Advisers, LP $556 552 26 068 0,21% Acciones
Inspire Investing, LLC $512 954 29 362 0,20% Acciones
Sanctuary Advisors, LLC $497 113 23 284 0,19% Acciones
Man Group plc $489 854 22 944 0,19% Acciones

Mostrar todos los 152 propietarios institucionales →

Activistas y propietarios del %+ 5 3 tenencias

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Gull Global Limited, Myron W. Wentz ×11 presentaciones 30 de marzo de 2026 40,10% Enmienda M&A / venta SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 23 de mayo de 2008 · Presentación inicial · SEC
Paul & Jane Meyer Family Foundation 20 de mayo de 2008 · Presentación inicial Inversión pasiva SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 38 insiders · 20 directivos · 13 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Jim Brown CEO & PRESIDENT 24 de julio de 2025 M 16 934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 27 de mayo de 2026 S 0 0 1 $-100 500
Jeffrey Yates Chief Financial Officer 28 de octubre de 2010 M 0 0 0 $0
Deborah Woo President of Asia 8 de septiembre de 2016 M 1 479 0 0 $0
Fred W Cooper President and COO 28 de octubre de 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 27 de febrero de 2026 M 9 256 0 0 $0
Roy Truett Chief Operating Officer 27 de julio de 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 25 de julio de 2026 M 3 471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 25 de julio de 2026 M 422 0 2 $-144 236
Brent Neidig CHIEF COMMERCIAL OFFICER 16 de junio de 2026 S 0 0 3 $-147 749
Paul A. Jones CHIEF PEOPLE OFFICER 8 de junio de 2026 S 0 0 2 $-231 984
Joshua Foukas CHIEF LEGAL OFFICER 7 de mayo de 2026 S 0 0 2 $-170 336
David Mulham Mulham CHIEF SALES OFFICER 10 de diciembre de 2025 S 8 387 0 1 $-18 333
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 2 de mayo de 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 5 de marzo de 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 5 de febrero de 2018 A 2 076 0 0 $0
Dave Wentz Co-C.E.O. 16 de agosto de 2016 M 384 883 0 0 $0
Rick Stambaugh Chief Information Officer 17 de diciembre de 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 28 de octubre de 2010 M 5 000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 25 de febrero de 2008 S 0 0 0 $0
Xia Ding Consejero 23 de julio de 2026 M 8 278 0 0 $0
John Turman Fleming Consejero 23 de julio de 2026 M 5 862 0 2 $-78 560
Peggie Pelosi Consejero 23 de julio de 2026 M 6 061 0 0 $0
Scott J Nixon Consejero 23 de julio de 2026 M 11 445 0 0 $0
Frederic J Winssinger Consejero 23 de julio de 2026 M 9 733 0 1 $-38 420
Timothy E Wood Consejero 23 de julio de 2026 M 11 837 0 0 $0
Gilbert A Fuller Consejero 23 de julio de 2026 M 1 632 0 3 $-60 414
Robert Auciaux Consejero 9 de mayo de 2022 M 8 092 0 0 $0
Feng Peng Consejero 28 de abril de 2021 M 755 0 0 $0
Myron W. Wentz Consejero 4 de febrero de 2019 S 9 865 614 0 0 $0
Jerry G Mcclain Consejero 4 de marzo de 2016 M 0 0 0 $0
Ronald S Poelman Consejero 8 de febrero de 2016 A 0 0 0 $0
Denis E Waitley Consejero 3 de noviembre de 2006 M 0 0 0 $0
Gull Global Limited Propietario del 10% 4 de febrero de 2019 S 9 865 614 0 0 $0
GULL HOLDINGS LTD Propietario del 10% 1 de abril de 2015 J 6 491 110 0 0 $0
Kevin Guest · 27 de febrero de 2026 M 45 381 0 0 $0
Donald R. Williams · 1 de mayo de 2017 A · 0 0 $0
Doug Braun · 16 de diciembre de 2015 M 0 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 22 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
VFVA · VANGUARD WELLINGTON FUND 0,11% 45 046 SH 19 de agosto de 2026 Diario
EBIT · Harbor ETF Trust 0,07% 367 NS 31 de julio de 2026 N-PORT
IWC · iShares Trust 0,04% 37 870 SH 11 de septiembre de 2026 Diario
VDC · VANGUARD WORLD FUND 0,03% 128 565 SH 19 de agosto de 2026 Diario
VTWV · VANGUARD SCOTTSDALE FUNDS 0,02% 9 639 SH 19 de agosto de 2026 Diario
DFSV · Dimensional ETF Trust 0,02% 67 386 NS 31 de julio de 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 24 234 SH 1 de octubre de 2026 Diario
DFAT · Dimensional ETF Trust 0,01% 67 428 NS 31 de julio de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 64 278 SH 19 de agosto de 2026 Diario
RSSL · Global X Funds 0,01% 5 337 NS 31 de julio de 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,01% 1 189 SH 1 de octubre de 2026 Diario
DFAS · Dimensional ETF Trust 0,01% 42 099 NS 31 de julio de 2026 N-PORT
IWM · iShares Trust 0,01% 283 783 SH 11 de septiembre de 2026 Diario
DFAC · Dimensional ETF Trust 0,00% 19 278 NS 31 de julio de 2026 N-PORT
ITOT · iShares Trust 0,00% 22 756 SH 11 de septiembre de 2026 Diario
IWV · iShares Trust 0,00% 3 720 SH 3 de septiembre de 2026 Diario
DFUS · Dimensional ETF Trust 0,00% 1 784 NS 31 de julio de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 124 681 SH 19 de agosto de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,00% 350 035 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 790 SH 19 de agosto de 2026 Diario
IWN · iShares Trust · 101 470 SH 11 de septiembre de 2026 Diario
SMLF · iShares Trust · 22 964 SH 11 de septiembre de 2026 Diario

USNA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 6 analistas VENTA
Objetivo mediano $25.00 +68,7%
0 0,0% Compra fuerte
0 0,0% Compra
3 50,0% Mantener
1 16,7% Venta
2 33,3% Venta fuerte

Precio objetivo a 12 meses

1 analistas · 2026-10-01

Objetivo medio $25.00 +68,7%

Mín$25.00 Media$25.00 Máx$25.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
EPC $946M 38.4 -1.3% 1.1% 1.7% 41.6%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Ago 13, 2026